➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Colorcon
Merck
Harvard Business School
Moodys

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

Patent: 5,366,728

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,366,728
Title: Stable forms of antigenic Taenia ovis polypeptides
Abstract:Stable forms of Taenia ovis peptide antigens, such as portions of a T. ovis oncosphere antigen which runs as a 47-52 kDa doublet, are suitable for use in vaccines to protect ruminants against infection by cestode parasites. The antigens are preferably obtained by isolation and expression of the DNA encoding them in recombinant host cells. Aspects of the invention include DNA encoding T. ovis antigens, vectors containing such DNA and host cells which express the T. ovis antigens.
Inventor(s): Harrison; Gavin B. L. (Upper Hutt, NZ), Dempster; Robert P. (Upper Hutt, NZ), Rickard; Michael D. (Werribee, AU), Lightowlers; Marshall W. (Victoria, AU), Heath; David D. (Paremata, NZ), Lawrence; Stephen B. (Upper Hutt, NZ), O\'Hoy; Kim L. (Pascoe Vale, AU)
Assignee: Pitman-Moore New Zealand Limited (Upper Hutt, NZ) The University of Melbourne (Melbourne, AU) Her Majestry the Queen in right of New Zealand through the Ministry of (Wellington, NZ)
Application Number:07/969,450
Patent Claims:see list of patent claims

Details for Patent 5,366,728

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Pitman-Moore New Zealand Limited (Upper Hutt, NZ) The University of Melbourne (Melbourne, AU) Her Majestry the Queen in right of New Zealand through the Ministry of (Wellington, NZ) 2008-01-06 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Pitman-Moore New Zealand Limited (Upper Hutt, NZ) The University of Melbourne (Melbourne, AU) Her Majestry the Queen in right of New Zealand through the Ministry of (Wellington, NZ) 2008-01-06 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Pitman-Moore New Zealand Limited (Upper Hutt, NZ) The University of Melbourne (Melbourne, AU) Her Majestry the Queen in right of New Zealand through the Ministry of (Wellington, NZ) 2008-01-06 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Mallinckrodt
AstraZeneca
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.